TR200001544T2 - New compounds. - Google Patents

New compounds.

Info

Publication number
TR200001544T2
TR200001544T2 TR2000/01544T TR200001544T TR200001544T2 TR 200001544 T2 TR200001544 T2 TR 200001544T2 TR 2000/01544 T TR2000/01544 T TR 2000/01544T TR 200001544 T TR200001544 T TR 200001544T TR 200001544 T2 TR200001544 T2 TR 200001544T2
Authority
TR
Turkey
Prior art keywords
new compounds
pharmaceutical compositions
compounds
therapy
preparation
Prior art date
Application number
TR2000/01544T
Other languages
Turkish (tr)
Inventor
Baxter Andrew
Cheshire David
Mcinally Thomas
Mortimore Michael
Cladingboel David
Original Assignee
Astrazeneca Uk Lmited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Lmited filed Critical Astrazeneca Uk Lmited
Publication of TR200001544T2 publication Critical patent/TR200001544T2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Bulus, yeni bilesikler, bunlarin hazirlanmasi için bir islem, bu bilesikleri içeren farmasötik bilesimler, farmasötik bilesimlerihazirlamak için bir islem ve bunlarin tedavide kullanilmasini öngörmektedir.The invention envisages new compounds, a process for their preparation, pharmaceutical compositions containing these compounds, a process for preparing pharmaceutical compositions, and their use in therapy.

TR2000/01544T 1997-12-05 1998-12-01 New compounds. TR200001544T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704546A SE9704546D0 (en) 1997-12-05 1997-12-05 Novel compounds

Publications (1)

Publication Number Publication Date
TR200001544T2 true TR200001544T2 (en) 2000-11-21

Family

ID=20409283

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01544T TR200001544T2 (en) 1997-12-05 1998-12-01 New compounds.

Country Status (16)

Country Link
EP (1) EP1037889A1 (en)
JP (1) JP2001525406A (en)
KR (1) KR20010032800A (en)
CN (1) CN1284074A (en)
AU (1) AU1791599A (en)
BR (1) BR9813378A (en)
CA (1) CA2312357A1 (en)
EE (1) EE200000321A (en)
HU (1) HUP0100731A3 (en)
IL (1) IL136368A0 (en)
NO (1) NO20002787L (en)
PL (1) PL340837A1 (en)
SE (1) SE9704546D0 (en)
SK (1) SK8442000A3 (en)
TR (1) TR200001544T2 (en)
WO (1) WO1999029686A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901875D0 (en) * 1999-05-25 1999-05-25 Astra Pharma Prod Novel compounds
SE9904505D0 (en) 1999-12-09 1999-12-09 Astra Pharma Prod Novel compounds
TWI258462B (en) 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
SE9904652D0 (en) * 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
JP2002330787A (en) * 2000-10-21 2002-11-19 Astrazeneca Ab Chemical substance
PA8557501A1 (en) 2001-11-12 2003-06-30 Pfizer Prod Inc BENZAMIDA, HETEROARILAMIDA AND INVESTED AMIDAS
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
PA8591801A1 (en) 2002-12-31 2004-07-26 Pfizer Prod Inc BENZAMID INHIBITORS OF THE P2X7 RECEIVER.
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
BRPI0410349A (en) 2003-05-12 2006-05-30 Pfizer Prod Inc p2x7 receptor benzamide inhibitors
GB0324498D0 (en) 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
WO2006003500A1 (en) 2004-06-29 2006-01-12 Pfizer Products Inc. Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers
EP2001474B1 (en) 2006-03-16 2016-03-09 Second Genome, Inc. Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
TWI464148B (en) 2006-03-16 2014-12-11 Evotec Us Inc Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
DK1937643T3 (en) 2006-03-16 2016-10-10 Second Genome Inc Bicycloheteroarylforbindelser som p2x7-modulatorer og anvendelser deraf
TW200813018A (en) 2006-06-09 2008-03-16 Astrazeneca Ab Novel compounds
GB0613473D0 (en) * 2006-07-06 2006-08-16 Glaxo Group Ltd Novel compounds
AU2007271182B2 (en) * 2006-07-06 2012-03-15 Glaxo Group Limited Substituted N-phenylmethyl -5-oxo-proline-2-amides as P2X7-receptor antagonists and their methods of use
DK2124562T3 (en) 2007-03-09 2016-08-01 Second Genome Inc BICYCLOHETEROARYLFORBINDELSER AS P2X7 modulators and uses thereof
EP2139858A1 (en) * 2007-03-28 2010-01-06 Glaxo Group Limited Piperidinone carboxamide derivatives as p2x7 modulators
EP2139875A2 (en) * 2007-03-29 2010-01-06 Glaxo Group Limited Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators
MX2009010759A (en) * 2007-04-03 2009-10-28 Glaxo Group Ltd Imidazolidine carboxamide derivatives as p2x7 modulators.
US8119661B2 (en) 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
GB0803729D0 (en) * 2008-02-29 2008-04-09 Ge Healthcare Ltd Imaging the central nervous system
PL2105164T3 (en) 2008-03-25 2011-05-31 Affectis Pharmaceuticals Ag Novel P2X7R antagonists and their use
PL2243772T3 (en) 2009-04-14 2012-05-31 Affectis Pharmaceuticals Ag Novel P2X7R antagonists and their use
EP2322149A1 (en) 2009-11-03 2011-05-18 Universidad del Pais Vasco Methods and compositions for the treatment of ischemia
WO2011141194A1 (en) 2010-05-14 2011-11-17 Affectis Pharmaceuticals Ag Novel methods for the preparation of p2x7r antagonists
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2019102354A1 (en) 2017-11-21 2019-05-31 3M Innovative Properties Company Oral plant-based-oil-in-water emulsions and methods of use
CN111511362A (en) 2017-12-20 2020-08-07 3M创新有限公司 Oral compositions and methods of use
CN111511348A (en) 2017-12-20 2020-08-07 3M创新有限公司 Oral compositions and methods of use

Also Published As

Publication number Publication date
IL136368A0 (en) 2001-06-14
PL340837A1 (en) 2001-02-26
SE9704546D0 (en) 1997-12-05
EP1037889A1 (en) 2000-09-27
AU1791599A (en) 1999-06-28
NO20002787L (en) 2000-08-01
EE200000321A (en) 2001-08-15
WO1999029686A1 (en) 1999-06-17
KR20010032800A (en) 2001-04-25
HUP0100731A3 (en) 2002-08-28
JP2001525406A (en) 2001-12-11
CN1284074A (en) 2001-02-14
BR9813378A (en) 2000-10-10
HUP0100731A2 (en) 2002-05-29
CA2312357A1 (en) 1999-06-17
NO20002787D0 (en) 2000-05-31
SK8442000A3 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
TR200001544T2 (en) New compounds.
EE200000320A (en) Novel compounds
SE9704544D0 (en) Novel compounds
TR199802423T2 (en) Concentrated antibody composition.
TR199900639T2 (en) Olanzapin dihydrate D.
EE9700044A (en) Heteroaryloxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds.
MY125978A (en) Admantane derivatives
TR200100299T2 (en) Therapeutic biaryl derivatives.
DE69905170D1 (en) Thiazolopyrimidinderivate
TR200100054T2 (en) Paroxetine methanesulfonate
TR200000152T2 (en) New compounds.
TR200002896T2 (en) Calcilitic Compositions
SE9802937D0 (en) Novel compounds
TR200003596T2 (en) Hypnotic beta-carboline derivatives, their use as process and medicinal product for their preparation
TR199800152T1 (en) Endothelin Receptor Antagonists
IL134039A0 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
EP1011329A4 (en) 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
ZA981275B (en) Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions.
ZA983243B (en) Novel aryl compounds, processes for their preparation, pharmacological compositions containing the same and their use in therapy.
ZA986139B (en) Sulphonamide compounds, processes for their preparation, pharmaceutical compositions containing the same and their use in therapy.
ZA9811804B (en) 11ß-halogen-7Ó-substituted estratrienes, process for the production of pharmaceutical preparations that contain these 11ß-halogen-7Ó-substituted estratrienes as well as their use for the production of pharmaceutical agents.
ZA983242B (en) Novel piperaline compounds, processes for their preparation pharmacological compositions containing the same and their use in therapy.